BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11082844)

  • 1. An alternative improved synthesis of (-)-norferruginine, a potent nAChR agonist.
    Wegge T; Schwarz S; Seitz G
    Pharmazie; 2000 Oct; 55(10):779-80. PubMed ID: 11082844
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors.
    Murineddu G; Murruzzu C; Curzu MM; Chelucci G; Gotti C; Gaimarri A; Legnani L; Toma L; Pinna GA
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6147-50. PubMed ID: 18938077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epibatidine structure-activity relationships.
    Carroll FI
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1889-96. PubMed ID: 15050621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and electrophysiological studies of a novel epibatidine analogue.
    Spang JE; Patt JT; Bertrand S; Bertrand D; Westera G; Schubiger PA
    J Recept Signal Transduct Res; 1999; 19(1-4):521-31. PubMed ID: 10071782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging.
    Dolci L; Dolle F; Valette H; Vaufrey F; Fuseau C; Bottlaender M; Crouzel C
    Bioorg Med Chem; 1999 Mar; 7(3):467-79. PubMed ID: 10220033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of (-)-epibatidine and its derivatives from chiral allene-1,3-dicarboxylate esters.
    Kimura H; Fujiwara T; Katoh T; Nishide K; Kajimoto T; Node M
    Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):399-402. PubMed ID: 16508202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses of (+/-)-homoepibatidine analogues.
    Kim YH; Oh CY; Lee KY; Lee YS; Jung YH; Park HJ; Ham WH
    Arch Pharm Res; 2002 Feb; 25(1):49-52. PubMed ID: 11885691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the research on nicotinic acetylcholine receptors agonists].
    Chen JH; Bai DL
    Yao Xue Xue Bao; 2002 Apr; 37(4):309-15. PubMed ID: 12579830
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of intramolecular enyne metathesis to the synthesis of aza[4.2.1]bicyclics: enantiospecific total synthesis of (+)-anatoxin-a.
    Brenneman JB; Martin SF
    Org Lett; 2004 Apr; 6(8):1329-31. PubMed ID: 15070329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and biological properties of cysteine-reactive epibatidine derivatives.
    Che C; Petit G; Kotzyba-Hibert F; Bertrand S; Bertrand D; Grutter T; Goeldner M
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1001-4. PubMed ID: 12643898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epibatidine. An old work principle rediscovered].
    Hecker T; Nieber K
    Med Monatsschr Pharm; 1999 Aug; 22(8):226-32. PubMed ID: 10481433
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists.
    O'Donnell CJ; Peng L; O'Neill BT; Arnold EP; Mather RJ; Sands SB; Shrikhande A; Lebel LA; Spracklin DK; Nedza FM
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4747-51. PubMed ID: 19576766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective α4β2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders.
    Mazurov AA; Miao L; Bhatti BS; Strachan JP; Akireddy S; Murthy S; Kombo D; Xiao YD; Hammond P; Zhang J; Hauser TA; Jordan KG; Miller CH; Speake JD; Gatto GJ; Yohannes D
    J Med Chem; 2012 Nov; 55(21):9181-94. PubMed ID: 22793665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epibatidine and pain.
    Traynor JR
    Br J Anaesth; 1998 Jul; 81(1):69-76. PubMed ID: 9771274
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel enantiopure ferrugininoids active as nicotinic agents: synthesis and radioligand binding studies.
    Seifert S; Stehl A; Tilotta MC; Gündisch D; Seitz G
    Pharmazie; 2004 Jun; 59(6):427-34. PubMed ID: 15248455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of heterocyclic analogues of epibatidine via 7-azabicyclo[2.2.1]hept-2-yl radical intermediates. 1. Intermolecular reactions.
    Gómez-Sánchez E; Soriano E; Marco-Contelles J
    J Org Chem; 2008 Sep; 73(17):6784-92. PubMed ID: 18656981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective syntheses of (+/-)-epibatidine analogues.
    Kim YH; Won DY; Oh CY; Lee KY; Lee YS; Woo NT; Park YH; Park HJ; Ham WH
    Arch Pharm Res; 2002 Feb; 25(1):45-8. PubMed ID: 11885690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.